OMESTI BHD
KLSE (MYR): OMESTI (9008)
You're accessing 15 mins delay data. Turn on live stream now to enjoy real-time data!
Last Price
0.305
Today's Change
-0.02 (6.15%)
Day's Change
0.305 - 0.315
Trading Volume
192,000
Overview
Market Cap
165 Million
NOSH
541 Million
Avg Volume (4 weeks)
149,931
4 Weeks Range
0.295 - 0.33
4 Weeks Price Volatility (%)
28.57%
52 Weeks Range
0.28 - 0.47
52 Weeks Price Volatility (%)
13.16%
Previous Close
0.325
Open
0.31
Bid
0.305 x 21,400
Ask
0.315 x 90,000
Day's Range
0.305 - 0.315
Trading Volume
192,000
Financial Highlight
Latest Quarter | Ann. Date
30-Sep-2023 [#2] | 30-Nov-2023
Next QR | Est. Ann. Date
31-Dec-2023 | 28-Feb-2024
T4Q P/E | EY
-3.51 | -28.46%
T4Q DY | Payout %
0.00% | 0.00%
T4Q NAPS | P/NAPS
0.57 | 0.53
T4Q NP Margin | ROE
-40.66% | -15.14%
Market Buzz
News and Blogs
Company Profile
Sector: TECHNOLOGY
Sector: TECHNOLOGY
Subsector: DIGITAL SERVICES
Subsector: DIGITAL SERVICES
Description:
Omesti Bhd is an investment holding company. They are principally engaged in the distribution, maintenance, and development of computer hardware and software and advisory and consultancy for computer software solutions. The subsidiaries in Singapore and Thailand are principally engaged in advisory and consultancy for computer software solutions. The group has three reportable segments: Business Performance Services, Trading and Distribution Services and Digital and Infrastructure services. Other segments comprise operations related to property development and investment holding activities. Majority of the company's revenue is derived from Malaysia.
Discussions
7 people like this. Showing 50 of 1,700 comments
They got 1 million doses of Sinovac....what other vaccines they will be getting?
2021-08-06 17:39
forget about this goreng stock, same as microln and others "stocks" unless you know when to exit.
many loss money because jump in and don't know when to jump out
2021-08-06 20:29
From Rakuten Trade's Research Hive:
Omesti Bhd (Fundamental BUY with TP 0.71)
Omesti Bhd (Omesti) is primarily involved in providing network connectivity and bandwidth services, and project management services in relation to telecommunications via its 51.8% subsidiary Microlink Bhd.
On 27 July 2021, the company acquired a 70% stake in Bemed Tempua Sdn. Bhd. (Bemed Tempua) for RM700,000 and is now a Covid-19 vaccine provider for the private sector.
Omesti jumped into the Covid-19 vaccine bandwagon and launched the Omesti Healthcare Vaccin8 Programme (“Healthcare Programme”) providing vaccination services to companies for their employees as part of the nationwide drive to achieve herd immunity status.
Authorised by the Jawatankuasa Khas Jaminan Akses Bekalan Vaksin COVID-19 (JKJAV) and the Ministry of Health Malaysia (MOH), the 1m doses of Sinovac vaccines acquired from Pharmaniaga enables Omesti to execute its Healthcare Programme. In addition, Omesti is also providing Oral Fluid Antigen Test Kit (approved by the MOH) to existing clients and via online marketing. Demand for its vaccines and test kits remains resilient as the company has already secured substantial orders from companies across different sectors.
Balance sheet is healthy with net cash position of RM27.7m as at FY21.
This new source of income will greatly enhance Omesti’s earnings for FY22 and beyond. BUY with a target price of RM0.71 based on sum of parts valuation, implying a forward PER of 16.5x for FY22. Our BUY recommendation is premised on: (i) strong sales achieved since the launch of Healthcare Programme; (ii) orders secured from the private sectors providing recurring earnings; and (iii) healthy profit margins going forward.
2021-08-24 12:00
.......1Q net profit 0.301 million (increased 6.74%)......27 Aug 2021 5:08PM
2021-09-08 16:08
.......Omesti Director....Mr. Monteiro Gerard Clair started to buy....
2021-09-08 16:14
......annoucement available on Bursa website.....https://www.bursamalaysia.com/market_information/announcements/company_announcement/announcement_details?ann_id=3182926
2021-09-13 08:57
Crazy nonstop buying from insider?
This counter would assist in 4g/5g or not .....from report looks only small bit
FA not really convincing...in fact revenue is stagnant if not going down lol
24 Sep 2021 Acquired
1,119,700 MR MONTEIRO GERARD CLAIR
24 Sep 2021 Acquired
1,119,700 MR MONTEIRO GERARD CLAIR
12 Aug 2021 Acquired
100,000 MR MONTEIRO GERARD CLAIR
12 Aug 2021 Acquired
100,000 MR MONTEIRO GERARD CLAIR
11 Aug 2021 Acquired
244,400 MR MONTEIRO GERARD CLAIR
11 Aug 2021 Acquired
244,400 MR MONTEIRO GERARD CLAIR
Digital &
Infrastructure
Services
RM'000
2,547
2021-09-29 00:44
Director loading up, Tunku Zain new CEO........ could something be brewing...... Picking up a few.......
2021-10-04 08:49
M&A Securities Sdn Bhd, on behalf of the Board of Directors of Omesti wishes to announce that the Company had on 19 January 2022 entered into a Heads of Agreement with Man Yau Holdings Berhad (“MYHB”), a wholly-owned subsidiary of Omesti, and Microlink Solutions Berhad (“Microlink”), wherein Omesti and MYHB on the one hand are desirous of undertaking the transfer of certain information technology projects to Microlink on the other hand, which will comprise and involve the following:
1. the proposed sale and transfer by Omesti of its rights and interests under the TMBSSP contracts in respect of a business support system project for Telekom Malaysia Berhad (“TMBSSP”), to Microlink (“Proposed Transfer of TMBSSP”);
2. the proposed sale and transfer by Omesti of 250,000 ordinary shares in Formis Research & Development Sdn Bhd, representing 100% of its equity interest, which is carrying out certain electronic services development and maintenance projects, to Microlink (“Proposed Share Sale of FRDSB”); and
3. the proposed sale and transfer by MYHB of 10,000 ordinary shares in Omesti Assist Sdn Bhd, representing 100% of its equity interest, which is also carrying out certain electronic services development and maintenance projects, to Microlink (“Proposed Share Sale of OASB”)
2022-01-19 21:19
What is Omdsti getting from Microlink for the 3 proposals.?
The RI last year was purported for proposal 1. What about the money raised for the project?
2022-01-25 11:07
The Board of Directors of Omesti Berhad (“the Company” or “Omesti”) wishes to announce that Omesti Berhad (“Omesti” or “the Company”), has on 23 September 2022 received and accepted a Letter of Award ("LOA") from Telekom Malaysia Berhad ("TM") for the “Agreement for Design, Development, Customization, Configuration, Delivery, Installation, Integration, Testing, Commissioning & Knowledge Transfer for Mobile Services Business Support System to Ensure Mobile Services Continuity (Including 5G and Other Mobile-Related Services), Maintenance and Support Services and Provision of Software Subscription for a period of one (1) year, commencing on 23 September 2022 to 22 September 2023 at a total value of RM20,000,000.00 (inclusive of Sales and Service Tax (SST) of 6%) with no clause on renewal in the LOA (hereinafter referred to as “the TM Contract”)...
2022-10-25 16:23
The Board of Directors of Omesti Berhad (“Omesti”) wishes to announce that Formis Network Services Sdn Bhd (“FNS”), an indirect 51% owned subsidiary of Omesti, has on 23 November 2022 accepted the award from the Chief Registrar’s Office of the Federal Court of Malaysia to provide maintenance and support services for Phase 2 e-COURTS System for a period of three (3) years, commencing on 1 December 2022 to 30 November 2025 for a total contract sum of RM33,849,222.53 (inclusive of Sales and Service Tax (SST) of 6%) with no clause on renewal in the award (hereinafter referred to as "the e-COURTS Maintenance Phase 2 Contract").
2022-11-29 12:10
I bought quite a lot at an average cost of 0.442 this morning.
Omesti is one of Microlink's major shareholders. ML went up from 0.6 to 1.00 in the past two months before. The flat base setup looks similar to ML's prior to its bull run.
Let's go!
2022-11-30 10:10
YEEEEEEEHAAAAAAAAA!!!!!!!
-----------------------------------------------------------
bojed
I bought quite a lot at an average cost of 0.442 this morning.
Omesti is one of Microlink's major shareholders. ML went up from 0.6 to 1.00 in the past two months before. The flat base setup looks similar to ML's prior to its bull run.
Let's go!
2 days ago
2022-12-02 20:49
It's easy to identify a non-performing company. Just look/read the company name and it will tell you, their intention.
2022-12-02 21:30
Revenue 20,893
PBT 168,048 (How is this possible when revenue is lower. Donation?? Lottery??)
NP 168,267 (How is this even possible when PBT is low than NP, LHDN returned tax??)
2022-12-02 21:34
on 8 May 2023.....reached the bottom orady at 0.280 (did some averaging here....) after that the movement has been quite ok....lets hope for the best....
2 months ago
Post a Comment
Featured Posts
MQ Trader
MQ Trading Signals
Time
Signal
Duration
Type
2023-12-08 15:45:00
EMA 5
5 Mins
SELL
2023-12-08 15:45:00
ADX
5 Mins
SELL
2023-12-08 15:10:00
EMA 5
5 Mins
BUY
2023-12-08 15:05:00
ADX
5 Mins
BUY
2023-12-08 12:30:00
EMA 5
30 Mins
SELL
Apps
Top Articles
2
THE INVESTMENT APPROACH OF CALVIN TAN
KELINGTON GROUP (0151) SOME RED FLAGS IN THIS STOCK YOU NEED TO KNOW, Calvin Tan
3
4
The Alpha Trader
5
BFM Podcast
6
BFM Podcast
7
BFM Podcast
8
BFM Podcast
#
Stock
Score
Daily Stocks
Stock Name
Last
Change
Volume
Stock Name
Last
Change
Volume
Stock Name
Last
Change
Volume
Featured Advertisers / Partners
Ride The Bull Short The Bear
CS Tan
4.9 / 5.0
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
rogers123
OMESTI LAUNCHES VACCIN8 PROGRAMME UNDER NEW
HEALTHCARE DIVISION
Technology group OMESTI Berhad has launched the OMESTI Healthcare Vaccin8
Programme to provide vaccination services to companies for their employees as
part of the nationwide drive to combat COVID-19.
The Programme, offered by the OMESTI Healthcare Division, will provide safe and convenient
access to vaccinations for Malaysian companies to protect as many of their employees as
quickly as possible and so help businesses resume normal operations. Authorised by the JKJAV
(Jawatankuasa Khas Jaminan Akses Bekalan Vaksin COVID-19) and the Ministry of Health
Malaysia, the Vaccin8 Programme enables OMESTI to lend its support to the National COVID19 Immunisation Programme (NCIP).
Gerard Monteiro, Executive Director of OMESTI Berhad, says, “We are honoured to be able to
do whatever we can to assist in the NCIP and help combat the COVID-19 Pandemic. We firmly
believe that mass-vaccination of the workforce, especially in Malaysia’s critically important
industries, is the only way to protect lives and ensure that livelihoods can be sustained.”
Mr Monteiro adds, “In setting up the OMESTI Healthcare Vaccin8 Programme, we have been
able to leverage our substantial technology heritage in the successful delivery of complex
multi-stakeholder systems to help roll out this vital initiative for the country. The sooner the
majority of the population is protected, the sooner the economy can regain its footing and we
can begin to open up to international business once more.”
OMESTI Berhad has invested in Bemed Tempua Sdn Bhd, a pharmaceutical company which
has been granted approval to acquire an initial allocation of one (1) million doses of the
Sinovac vaccine from Pharmaniaga LifeScience Sdn Bhd.
OMESTI has also engaged the services of licensed healthcare provider Mudah Healthcare Sdn
Bhd (Mudah Healthcare) as its delivery partner for the Vaccin8 Programme. “Our medical
teams will be mobilised to carry out vaccinations on site at company premises, even in remote
locations, offering safety, convenience and flexibility while minimising disruption to business
operations. Appointments can also be arranged at clinics and medical centres convenient to
company premises,” adds Mr Monteiro.
Page 2 of 2
Once completed, all details of the COVID-19 vaccinations provided under the OMESTI Vaccin8
Programme will be reflected in MySejahtera to ensure a reliable and complete ‘single source
of truth’ on the status of vaccinated individuals in Malaysia.
The Vaccin8 Programme has already attracted significant interest from Malaysian companies
and conglomerates in the financial services, plantation, manufacturing and hospitality sectors.
COVID-19 testing services will also be added to the Group’s portfolio in the near future,
enabling companies to conduct mass-testing of employees. This will help contain the risk of
infection, while ensuring compliance with the mandatory requirements for testing that apply
to many industry sectors under the Government SOPs.
Companies that are interested in obtaining vaccinations for their employees simply need to
email vaccin8@omesti.com.
www.vaccin8.omesti.com
……..
About OMESTI
OMESTI Berhad is a Malaysian-based public listed grouping of companies that specialises in helping
clients achieve digital transformation of their operations on both an enterprise-wide and modular basis.
Its portfolio includes proprietary solutions for digital court technology, corporate registry systems and
core banking as well as e-payments, data services, digital HR, cloud applications and IoT solutions.
It is an authorised technology/distribution partner for some of the world’s leading principals including
Huawei, IBM, Lenovo, HPE, Oracle, AWS, Alibaba and Google. It works with large enterprises across
multiple industry sectors including financial institutions, telecommunications, utility and energy firms,
the judiciary, regulatory bodies, education and various government departments. The Group also
provides solutions on an as-a-service basis for e-payments, royalty management, corporate secretarial,
human capital management, and more. www.omesti.com
2021-07-27 23:02